leisure time -WSS

leisure time

author：explore 2025-09-30 00:39:34 - browse：3

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Chinese researcher claims birth of first gene

knowledge

WSS

Mirador, a new biotech startup, launches with $400 million

Biden administration plans revamp of organ transplant system

Steward Health Care expansion into Malta flopped

Yancopoulos of Regeneron works to expand Dupixent success

Eli Lilly’s Mounjaro succeeds in second weight

Readout Newsletter: Illumina, CRISPR, Regeneron

knowledge

leisure time

focus

Guidelines to prevent youth baseball injuries need more muscle

Millions may soon lose Medicaid when they don't have to

Walensky prepares to leave CDC — and Congress — behind

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Heart attack and stroke risk calculators need revising

Mirador, a new biotech startup, launches with $400 million

The cancer drug shortage isn’t new — and neither are the solutions

Yancopoulos of Regeneron works to expand Dupixent success

At least 13 dead in Texas as scorching temps continue

CRISPR technology availability, affordability needs to be expanded

leisure time

Pregnancy ages women, but effects reverse after delivery

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Millions may soon lose Medicaid when they don't have to

Millions may soon lose Medicaid when they don't have to

Millions may soon lose Medicaid when they don't have to

explore

knowledge

knowledge

focus